US-based digital health company Redi Health has secured $14m in a Series B funding round led by Blue Heron Capital.

Refinery Ventures, Mutual Capital Partners, Rev1 Ventures and M25 were among the other investors who contributed to the round.

Redi Health plans to use the investment to foster innovation, develop and roll out new products, expand its patient network and expedite its growth.

The company aims to improve patient health outcomes by integrating pharmaceutical companies, providers and patients on a unified platform.

Redi Health co-founder and CEO Luke Buchanan said: “With Blue Heron Capital's backing, we are at a pivotal moment where we can significantly enhance patient care and outcomes.

“This investment validates the hard work of our team and the unwavering support of our investors as we aim to make comprehensive care accessible to millions more across the country.”

Redi Health’s mobile platform is designed to allow patients to manage all aspects of their health, from multiple medications and symptoms to diet and exercise.

It offers a comprehensive approach to patient care, including medication reminders, symptom management, educational resources and real-time information exchange.

Blue Heron Capital partner Gordon Crenshaw said: “Our investment in Redi is not merely a financial decision; it's an embodiment of our trust in the co-founders' vision, talent and grit.

“We are eager to support these entrepreneurs as they empower patients to improve their health journey.”

Blue Heron Capital said its investment in Redi Health is part of the company's 'commitment to fostering innovation that transcends boundaries and empowers patients'.

Blue Heron OA Collaborative member Jim Clair has joined Redi Health's board of directors following the investment.

Clair said: “Redi Health's innovative approach to digital healthcare sets them apart in today's rapidly evolving industry.

“We are impressed by Redi Health's commitment to improving patient outcomes and their ability to scale effectively.”